Is 1.7 mg of Wegovy a lot, or is it just part of the plan?

Where does 1.7 mg sit in the Wegovy schedule?

Wegovy's licensed titration moves through five doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. Each step is typically held for around four weeks before moving on. So if you're at 1.7 mg, you're roughly three months into treatment and one rung below the dose used in the main clinical evidence. You can read more about the full progression on our Wegovy doses overview.

The schedule isn't arbitrary. Semaglutide slows gastric emptying and suppresses appetite through GLP-1 receptor activation, and both effects become more pronounced as the dose rises. Going up gradually gives the body time to adapt. Jumping straight to a high dose would, for most people, produce unpleasant gastrointestinal effects that are far easier to avoid than to manage retrospectively. The NHS semaglutide medicines page describes this titration approach clearly for anyone who wants the patient-level detail.

So no, 1.7 mg is not a high dose in absolute terms. It's a step. Whether it feels significant depends on what you experienced at 1 mg, and if that lower dose was already well tolerated, moving to 1.7 mg is typically straightforward.

Does the amount in the pen match what it says on the label?

A reasonable question, and one worth checking. The Wegovy 1.7 mg pen delivers exactly 1.7 mg per weekly injection. The volume in the barrel is small, if you're curious about the liquid measure, our page on how many ml is in a 1.7 mg Wegovy dose covers that precisely.

One practical habit worth building: before each injection, check the label on the pen carton against the dose your prescriber has confirmed. It takes under a minute, and it's the simplest way to catch a dispensing mix-up before it happens. Pens come in different strengths within the same outer packaging style, so a visual check matters.

Each pen is pre-filled and pre-set at the factory. There's no dial to adjust, no way to accidentally deliver more or less than the stated dose. The mechanics are straightforward; the clinical judgement around timing is what varies from person to person.

Will 1.7 mg produce weight loss on its own?

The short answer is: it can, but the primary evidence base for Wegovy sits at the 2.4 mg maintenance dose. The STEP 1 trial, published in the New England Journal of Medicine, found an average body-weight reduction of around 15% over 68 weeks at 2.4 mg, alongside a reduced-calorie diet and increased physical activity.

Some people do lose weight meaningfully at 1.7 mg, particularly those who are very sensitive to semaglutide. Others find appetite suppression is present but modest at this level, and that 2.4 mg makes a perceptible difference. There's no single answer because semaglutide's effect varies with body composition, diet, activity, and individual pharmacology. The 1.7 mg Wegovy page explores what patients typically report at this dose in more detail.

What matters clinically is that 1.7 mg is rarely where the conversation ends. If you're tolerating it well and your prescriber is satisfied with your response, progression to 2.4 mg is the expected next step. If side effects are still present, staying at 1.7 mg for longer is a legitimate clinical decision. Either way, it's a conversation, not a ceiling.

How does 1.7 mg compare to what people think of as the 'standard' dose?

The phrase 'standard dose' usually means 2.4 mg, that's the maintenance dose Wegovy is titrated toward, and the one that appears in the headline trial data. At 1.7 mg you're close, which is precisely why many people start noticing more noticeable effects at this stage: reduced hunger between meals, smaller portions feeling satisfying, less preoccupation with food. These are real, physiological changes, not placebo.

For context on how 1.7 mg sits relative to the endpoint, comparing it to 2.4 mg is useful, that page covers what moving to maintenance actually involves. And if you're wondering whether staying at 1 mg might be right for you, that's a clinical question your prescriber can answer based on your response to each step.

Treatment pricing at each stage is something many people think about too. Our Wegovy prices page gives an honest picture of what private treatment costs in the UK, including what a legitimate price should cover. For anyone considering a clinically supervised route, starting a free consultation is the first step, a GPhC-registered prescriber, not an algorithm, reads every application the same day.